Richard Insel, M.D. oversees the research strategy at the JDRF, the worlds’ largest funder of type 1 diabetes research with an annual research budget over $100M that is focused on curing, treating, and preventing type 1 diabetes. Prior to joining JDRF in 2003, Dr. Insel was founding Director of the Center for Human Genetics and Molecular Pediatric Disease and Professor of Pediatrics and Microbiology/ Immunology at the University of Rochester Medical Center. During his 26-year affiliation with the University of Rochester Medical Center, he held several positions including, Director of the Strong Children’s Research Center, and Chief of the Division of Pediatric Immunology, Allergy, and Rheumatology, Acting Chair of Pediatrics. His research program at the University focused on immune responses to bacterial vaccines, including polysaccharide and protein-polysaccharide conjugate vaccines, and B lymphocyte immunity. Dr. Insel received pediatric and immunology training at Boston Children’s Hospital, Harvard Medical School, St. Mary’s Hospital, London, England, and the Center for Disease Control and is certified by the American Board of Pediatrics and the American Board of Allergy and Immunology.
Among other topics, we’ll be discussing recent news of JDRF’s support for Janssen Pharmaceutical’s Disease Interception Approach to the prevention of type 1 diabetes.

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube